GH Research (GHRS) Equity Average (2021 - 2025)

GH Research (GHRS) recorded quarterly Equity Average of $285.6 million in Q4 2025, down 3.95% quarter-over-quarter from $297.3 million in Q3 2025, and up 55.06% on a YoY basis from $184.2 million in Q4 2024.

GH Research (GHRS) Equity Average (2021 - 2025) Analysis & Trends

GH Research's Equity Average history runs 5 years deep, the most recent figure standing at $285.6 million for Q4 2025.

  • In Q4 2025, Equity Average rose 55.06% year-over-year to $285.6 million; the TTM figure through Dec 2025 stood at $285.6 million (up 55.06% YoY), while the FY2025 annual figure was $229.3 million, up 15.26% from the prior year.
  • Equity Average was $285.6 million for Q4 2025 at GH Research, down from $297.3 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $306.7 million in Q2 2025 to a low of $184.2 million in Q4 2024.
  • Historically, Equity Average has averaged $247.0 million across 5 years, with a median of $245.8 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Equity Average slipped 17.18% in 2024, then surged 55.06% in 2025.
  • A 5-year view of Equity Average shows it stood at $280.4 million in 2021, then decreased by 9.67% to $253.3 million in 2022, then fell by 12.2% to $222.4 million in 2023, then retreated by 17.18% to $184.2 million in 2024, then jumped by 55.06% to $285.6 million in 2025.
  • The last three Equity Average figures came in at $285.6 million (Q4 2025), $297.3 million (Q3 2025), and $306.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 3.50 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 783.14 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 3.76 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.01 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 21.35 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.01 Bn
9 Abivax 94.26 Bn 94.26 Bn - 516.41 Mn
10 GH Research 9.73 Bn 9.63 Bn - 285.55 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 285.55 Mn
Sep 30, 2025 297.29 Mn
Jun 30, 2025 306.70 Mn
Mar 31, 2025 244.58 Mn
Dec 31, 2024 184.16 Mn
Sep 30, 2024 194.02 Mn
Jun 30, 2024 204.21 Mn
Mar 31, 2024 214.36 Mn
Dec 31, 2023 222.37 Mn
Sep 30, 2023 229.38 Mn
Jun 30, 2023 237.41 Mn
Mar 31, 2023 245.82 Mn
Dec 31, 2022 253.28 Mn
Sep 30, 2022 259.98 Mn
Jun 30, 2022 266.35 Mn
Mar 31, 2022 273.33 Mn
Dec 31, 2021 280.39 Mn